CINECA IRIS Institutional Research Information System

DE MARIA, Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.991
EU - Europa 3.522
AS - Asia 1.975
SA - Sud America 207
AF - Africa 71
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.932
IT - Italia 1.266
CN - Cina 707
SG - Singapore 670
DE - Germania 461
IE - Irlanda 321
SE - Svezia 238
FI - Finlandia 226
FR - Francia 226
BR - Brasile 170
GB - Regno Unito 159
JP - Giappone 149
UA - Ucraina 133
KR - Corea 127
PL - Polonia 120
AT - Austria 103
VN - Vietnam 93
IN - India 85
SN - Senegal 60
ID - Indonesia 43
NL - Olanda 43
ES - Italia 39
BE - Belgio 38
CA - Canada 38
AU - Australia 36
HK - Hong Kong 33
PT - Portogallo 29
CH - Svizzera 25
RU - Federazione Russa 23
TW - Taiwan 21
GR - Grecia 16
MX - Messico 16
TR - Turchia 14
CL - Cile 9
NO - Norvegia 9
RO - Romania 9
TH - Thailandia 8
AR - Argentina 7
CO - Colombia 7
HU - Ungheria 7
LT - Lituania 7
DK - Danimarca 5
EU - Europa 5
MC - Monaco 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
LV - Lettonia 4
PE - Perù 4
PK - Pakistan 4
UZ - Uzbekistan 4
CU - Cuba 3
EC - Ecuador 3
HR - Croazia 3
NG - Nigeria 3
PY - Paraguay 3
UY - Uruguay 3
ZA - Sudafrica 3
BD - Bangladesh 2
IR - Iran 2
MA - Marocco 2
MY - Malesia 2
SA - Arabia Saudita 2
SD - Sudan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
JO - Giordania 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
VE - Venezuela 1
Totale 10.809
Salva come PNG Salva come JPEG
Città #
Chandler 529
Beijing 348
Dublin 321
Singapore 320
Torino 314
Fairfield 289
Santa Clara 279
Ann Arbor 270
Ashburn 252
Houston 237
Woodbridge 174
Wilmington 160
Seattle 144
Villeurbanne 137
Pisa 125
Medford 118
Nyköping 117
Redwood City 117
Cambridge 116
Dearborn 110
Princeton 109
Warsaw 108
Munich 103
Turin 95
Jacksonville 93
Columbus 92
Vienna 77
Helsinki 74
Guangzhou 53
Pune 53
Tokyo 50
Dong Ket 47
Fremont 46
Boston 45
Milan 44
Boardman 42
Jakarta 42
Nanjing 33
Hefei 29
Brussels 27
San Diego 25
São Paulo 23
New York 22
Silver Spring 22
Hong Kong 21
Philadelphia 20
Bologna 19
Norwalk 19
Shanghai 19
Los Angeles 18
Toronto 18
Rome 17
Utrecht 16
Nuremberg 15
Falls Church 14
London 14
Nürnberg 13
Shenyang 13
Taipei 13
Buffalo 12
Chongqing 12
Dallas 12
Davis 12
Verona 12
Camerino 11
Hangzhou 11
Kunming 11
Wuhan 11
Bottanuco 10
Des Moines 10
Hebei 10
Jinan 10
Padova 10
West Lafayette 10
Genoa 9
Oslo 9
The Dalles 9
Columbia 8
Leawood 8
Lisbon 8
Napoli 8
Osaka 8
Rio de Janeiro 7
Sydney 7
Urbana 7
Zhengzhou 7
Zurich 7
Chengdu 6
Florence 6
Genova 6
Paris 6
Phoenix 6
Washington 6
Catania 5
Cincinnati 5
Duncan 5
Düsseldorf 5
Falkenstein 5
Frankfurt am Main 5
Gent 5
Totale 6.417
Salva come PNG Salva come JPEG
Nome #
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination 594
PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines. 393
PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis 367
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 348
Chondroitin sulfate proteoglycan 4: A biomarker and potential immunotherapeutic target for canine malignant melanoma 335
CSPG4: a prototype oncoantigen for translational immunotherapy studies 282
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models 271
In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity 268
PDGFs/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 239
Activation of AKT2 in feline mammary carcinoma: a new prognostic factor in feline mammary tumors 232
Attività ed espressione dell'enzima 3-beta-idrossisteroide deidrogenasi in testicoli sani e criptorchidi di suino 224
Expression of the Short Form of RON/STK in Feline Mammary Carcinoma 193
Corticosteroid Hormone Receptors and Prereceptors as NewBiomarkers of the Illegal Use of Glucocorticoids in Meat Production 192
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas 190
IN-VITRO ESTABLISHMENT AND CHARACTERIZATION OF MYOEPITHELIAL CELL LINES FROM FOUR CANINE MAMMARY CARCINOMAS AND TWO NORMAL MAMMARY GLANDS 186
Inter-laboratory comparison of a yeast bioassay for the determination of estrogenic activity in biological samples 178
Isolation, purification, culture and characterisation of myoepithelial cells from normal and neoplastic canine mammary glands using a magnetic-activated cell sorting separation system. 176
Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index 166
Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 162
Progesterone receptor up-regulation: a diagnostic tool for the illicit use of oestrogens in adult beef cattle. 147
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 144
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma. 141
Heat shock protein expression in canine osteosarcoma 136
17beta-oestradiol-induced gene expression in cattle prostate: biomarkers to detect illegal use of growth promoters 134
Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma 132
17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines 121
Progesterone receptor gene expression in the accessory sex glands of veal calves 120
Application of absolute qPCR as a screening method to detect illicit 17-betaestradiol administration in male cattle 119
Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle 108
A RIKILT yeast estrogen bioassay (REA) for estrogen residue detection in urine of calves experimentally treated with 17-betaestradiol. 107
Expression of PDGFRs receptors in canine mammary carcinomas: pathological and clinical implications 104
Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma 104
MUCOPOLYSACCHARIDOSIS VI IN A SIAMESE/SHORT-HAIRED EUROPEAN CAT 102
Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization 100
Progesterone receptor gene over-expression in target organs following 17beta-estradiol treatment in veal calves 100
Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland 97
A NEW FORM OF GMI-GANGLIOSIDOSIS IN TWO KORAT CATS 94
Effects of Two Concentrations of a Clinical Propofol Formulation on Canine Mammary Tumor Cells NET1 Gene Expression: A Preliminary Evaluation of Possible Anti-Metastatic Properties 93
Valutazione dell'espressione del recettore del progesterone tramite qPCR assoluta nei bovini 91
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 89
Valutazione dell’espressione genica dell’enzima 11betaHSD 1 e 2 in colture di adipociti bovini trattati con desametazone e prednisolone. 88
TP53 EXPRESSION AND ANALYSIS OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPS) IN FELINE SQUAMOUS CARCINOMAS 88
Mucopolysaccharidosis VI in a Siamese/short-haired European cat. 88
Attivazione e caratterizzazione molecolare dell’oncogene AKT nei tumori mammari felini. 87
Identification of potential biomarkers for the illegal glucocorticoids treatment in cattle 82
Progesteron receptor gene up-regulation: a screening tool to detect estrogen illicit use in beef cattle 81
Co-expression of PDGFR Alpha and Beta in Canine Osteosarcomas Cell Lines and Tissues: New Targets for Innovative Therapeutic Strategies. 81
Mucopolysaccaridosis VI in a Siamese/short-haired European cat 78
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 78
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma 77
Procedimento e Kit per la rilevazione della somministrazione di sostanze estrogeniche esogene nei bovini 76
I modelli animali spontanei per lo studio della fisiologia e patologia dell'uomo 76
Beta Galactosidase deficiency in a Korat cat: a new form of feline GM1 gangliosidosis 75
Response to toceranib in dogs with measurable, unresectable, recurrent or metastatic mammary carcinomas 75
Canine mammary tumour cells exposure to sevoflurane: effects on proliferation and neuroepithelial transforming gene 1 expression 73
Molecular characterization and activation of AKT oncogene in feline mammary tumors 71
Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine 70
VACCINATION WITH HUMAN HMW-MAA DNA INDUCES A SPECIFIC ANTIBODY RESPONSE IN DOGS WITH MELANOMASIC 68
Ruolo del pathway PDGFRs/PDGFs nell'osteosarcoma canino: studio di bersagli molecolari per strategie terapeutiche innovative. 67
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative tumors 66
Correlation of PDGFRs with histotype and clinical outcome in canine thyroid carcinoma 66
Expression of mammalian target of rapamycin (mTOR) in feline mammary tumors: a potential target therapy in triple negative cancer 65
Platelet derived growth factor receptors expression in dogs affected by malignant oral melanomas: correlation with prognosis 65
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines 64
PDGFR expression is correlated to worse prognosis in dogs affected by malignant oral melanomas 64
OXT gene up-regulation in bovine skeletal muscle induced by dexamethasone and 17-beta-estradiol. 63
THE PRESENCE OF SHORT FORM OF RON/STK TRANSCRIPT COULD BE A PREDICTOR OF POOR OUTCOME IN FELINE MAMMARY CARCINOMA 62
Espressione dell’ HMW-MAA nei melanoma orali canini come potenziale target terapeutico nell’immunoterapia. 61
PDGFS/PDGFRs in canine osteosarcomas: new targets for innovative therapeutical strategies in comparative oncology 59
PCNA overexpression in bovine experimentally treated with 17 beta estradiol 58
Tumour grading and the one year post-surgical prognosis in feline mammary carcinomas. 58
The heat Shock Protein 90 inhibitor 17-AAG induces antiproliferative and apoptotic effects in canine osteosarcoma cell lines 57
IMMUNOHISTOCHEMICAL EXPRESSION OF MATRIX METALLOPROTEINASE 2 (MMP-2) IN FELINE FIBROADENOMATOUS CHANGE 57
Feline stk gene expression in cat mammary carcinomas 56
The presence of the short form of RON/STK transcript is a prognostic factor of poor outcome in feline mammary carcinomas 55
Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines 55
RON and MET oncogene expression in cat mammary tumors 54
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications 52
Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer 50
PDGFR receptors: new targeted therapy in canine osteosarcoma 50
An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology 50
Gene expression induced by 17 estradiol in bovine prostatic stromal cells: a way for the identification of molecular markers involved in the illegal use of growth promoters 48
HEAT SHOCK PROTEIN EXPRESSION IN CANINE OSTEOSARCOMA 48
Molecular and immunohistochemical studies on RON and MET oncogenes in cat mammary tumors 47
Lesioni indotte dalla somministrazione illecita di promotori della crescita negli animali da carne 47
E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis 47
Role of betha catenin in canine osteosarcoma 45
Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. 43
Quantitative HER2/neu gene expression in feline mammary tumors 43
Gene expression induced by 17b-estradiol in bovine cultured stromal cells 43
Ultrastructural Investigation of Canine osteosarcoma Cells killed by 17-AGG (17 Allylamino 17- demethoxygeldanamycin) through autophagy/apoptosia/necrosis 43
I tumori spontanei negli animali come modelli di studio per l'oncologia comparata 42
The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas 41
RON and MET oncogene expression in cat mammary tumors 41
null 41
Hypoxia-associated markers in the prognosis of oral canine melanoma 39
Expression of alpha and beta estrogen receptor in veal cattle treated with clenbuterol. 37
Feline STK gene expression in mammary carcinomas 37
Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol 37
The Italian-Canine Cancer Biobank: Our 10-year challenge 37
Totale 10.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.820
article - articoli 0
book - libri 0
conference - conferenze 10.296
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 0 0 0 0 0 0 103 79
2020/20211.216 111 104 94 72 93 97 84 48 158 145 58 152
2021/20221.169 65 58 72 56 44 62 82 64 36 112 257 261
2022/20231.659 176 135 38 149 179 416 128 95 163 42 87 51
2023/2024771 111 111 44 40 44 140 34 42 3 45 56 101
2024/20251.949 33 128 92 190 540 161 131 145 353 153 23 0
Totale 11.226